{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:20:10Z","timestamp":1790626810458,"version":"4.1.0"},"reference-count":15,"publisher":"Impact Journals, LLC","issue":"51","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,12,20]]},"DOI":"10.18632\/oncotarget.11319","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T22:15:12Z","timestamp":1471644912000},"page":"85584-85591","source":"Crossref","is-referenced-by-count":37,"title":["Phase II trial of concurrent chemoradiotherapy with L-asparaginase and MIDLE chemotherapy for newly diagnosed stage I\/II extranodal NK\/T-cell lymphoma, nasal type (CISL-1008)"],"prefix":"10.18632","volume":"7","author":[{"given":"Dok Hyun","family":"Yoon","sequence":"first","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Hyun","family":"Jeong","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Yeop","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Hwa","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junshik","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seong Kyu","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Hematology\/Oncology, Soonchunhyang University Bucheon Hospital, Bucheon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Young","family":"Yhim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonbuk National University School of Medicine, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deok-Hwan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyewon","family":"Lee","sequence":"additional","affiliation":[{"name":"Center for Hematologic Malignancies, National Cancer Center, Goyang, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jin","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Hong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Hematology-Oncology, Konkuk University Medical Center, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeon-Seok","family":"Eom","sequence":"additional","affiliation":[{"name":"Center for Hematologic Malignancies, National Cancer Center, Goyang, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Yong","family":"Kwak","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chonbuk National University School of Medicine, Jeonju, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae Hoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheolwon","family":"Suh","sequence":"additional","affiliation":[{"name":"Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Seog","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,8,16]]},"reference":[{"issue":"4","key":"1","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2005.04.1384","article-title":"Extranodal natural killer T-cell lymphoma, nasal-type: a prognostic model from a retrospective multicenter study","volume":"24","author":"Kim","year":"2006","journal-title":"Journal of clinical oncology"},{"issue":"11","key":"2","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1007\/s00277-014-2137-6","article-title":"Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK\/T cell lymphoma: CISL08-01 phase II study","volume":"93","author":"Kim","year":"2014","journal-title":"Annals of hematology"},{"issue":"35","key":"3","doi-asserted-by":"crossref","first-page":"6027","DOI":"10.1200\/JCO.2009.23.8592","article-title":"Phase II trial of concurrent radiation and weekly cisplatin followed by VIPD chemotherapy in newly diagnosed, stage IE to IIE, nasal, extranodal NK\/T-Cell Lymphoma: Consortium for Improving Survival of Lymphoma study","volume":"27","author":"Kim","year":"2009","journal-title":"Journal of clinical oncology"},{"issue":"33","key":"4","doi-asserted-by":"crossref","first-page":"5594","DOI":"10.1200\/JCO.2009.23.8295","article-title":"Phase I\/II study of concurrent chemoradiotherapy for localized nasal natural killer\/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211","volume":"27","author":"Nawano","year":"2009","journal-title":"Journal of clinical oncology"},{"issue":"22","key":"5","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1002\/cncr.26167","article-title":"Failure patterns and clinical implications in early stage nasal natural killer\/T-cell lymphoma treated with primary radiotherapy","volume":"117","author":"Yu","year":"2011","journal-title":"Cancer"},{"issue":"33","key":"6","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1200\/JCO.2011.35.6287","article-title":"Phase II study of SMILE chemotherapy for newly diagnosed stage IV, relapsed, or refractory extranodal natural killer (NK)\/T-cell lymphoma, nasal type: the NK-Cell Tumor Study Group study","volume":"29","author":"Oshimi","year":"2011","journal-title":"Journal of clinical oncology"},{"issue":"7","key":"7","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/10428190600562823","article-title":"First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +\/- radiotherapy is active in stage I\/II extranodal NK\/T-cell lymphoma","volume":"47","author":"Kim","year":"2006","journal-title":"Leukemia & lymphoma"},{"issue":"2","key":"8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/1043454212471728","article-title":"Managing hypersensitivity to asparaginase in pediatrics, adolescents, and young adults","volume":"30","author":"Koontz","year":"2013","journal-title":"Journal of pediatric oncology nursing"},{"issue":"15","key":"9","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2012-05-431460","article-title":"SMILE for natural killer\/T-cell lymphoma: analysis of safety and efficacy from the Asia Lymphoma Study Group","volume":"120","author":"Chim","year":"2012","journal-title":"Blood"},{"issue":"10","key":"10","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.20255","article-title":"High-dose methotrexate-induced nephrotoxicity in patients with osteosarcoma","volume":"100","author":"Adamson","year":"2004","journal-title":"Cancer"},{"issue":"3","key":"11","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1470-2045(15)00533-1","article-title":"A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: a multicentre, retrospective analysis","volume":"17","author":"Lee","year":"2016","journal-title":"The Lancet Oncology"},{"issue":"3","key":"12","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ijrobp.2015.07.2267","article-title":"Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer\/T-Cell Lymphoma, Nasal Type","volume":"93","author":"Ko","year":"2015","journal-title":"International journal of radiation oncology, biology, physics"},{"issue":"5","key":"13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/10428190902803669","article-title":"Whole blood Epstein-Barr virus DNA load as a diagnostic and prognostic surrogate: extranodal natural killer\/T-cell lymphoma","volume":"50","author":"Kim","year":"2009","journal-title":"Leukemia & lymphoma"},{"issue":"2","key":"14","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1016\/S2352-3026(15)00002-2","article-title":"Risk stratification on the basis of Deauville score on PET-CT and the presence of Epstein-Barr virus DNA after completion of primary treatment for extranodal natural killer\/T-cell lymphoma, nasal type: a multicentre, retrospective analysis","volume":"2","author":"Kim","year":"2015","journal-title":"The Lancet Haematology"},{"issue":"4","key":"15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group","volume":"17","author":"Armitage","year":"1999","journal-title":"Journal of clinical oncology"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11319","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T13:10:20Z","timestamp":1596719420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,16]]},"references-count":15,"journal-issue":{"issue":"51","published-print":{"date-parts":[[2016,12,20]]}},"alternative-id":["11319","27542213"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11319","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,16]]}}}